Effects of exercise on brain function in chronic cannabis users
Official title: Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users
Run by University Hospital, Lille · NCT06081218 · Data updated 2026-11-12
This study is testing how exercise affects brain function and health in people who regularly use cannabis compared to those who don't.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille) |
| Status | Recruiting |
| Started | May 7, 2024 |
| Main results expected | May 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | May 15, 2026 |
| Trial ID | NCT06081218 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include chronic cannabis users who meet specific consumption criteria and healthy individuals with no recent cannabis use.
✕Probably not a fit
Patients with other substance use disorders, neurological disorders, or significant obesity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how acute exercise influences cognitive functions and blood markers related to brain plasticity in individuals who regularly use cannabis. It aims to compare the endocannabinoid system's response to exercise between chronic cannabis users and non-users. Participants will undergo activity tests to assess these effects, focusing on the relationship between exercise and neurogenesis. The study seeks to understand the potential benefits of exercise in modifying the effects of chronic cannabis use on brain health.
Why it matters
Potential benefit: If successful, this study could provide insights into how exercise may improve cognitive function and brain health in chronic cannabis users.
How similar studies have gone: While the specific approach of this study is novel, previous research has indicated potential benefits of exercise on brain health, suggesting a promising area of investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Cannabis consumer group: * Cannabis consumption \> 100 times in lifetime, last exposure \< 7 days, and recent exposure \> 10 times in the month. * Positive toxicological urine test for ∆-9-THC. * Having a cannabis use disorder according to the CAST. Healthy group: * Negative urine toxicological test for cannabis. * No regular cannabis use for more than 6 months once in a lifetime. * No cannabis consumption in the 6 months preceding the study. Exclusion Criteria: For all subjects : * Disorders of use of other substances (alcohol, cocaine, opioid, or synthetic drugs). * Alcohol consumption greater than 30g per day (averaged over one week) and/or alcohol abuse the week preceding the visit. * Under medical treatment. * Presence of diagnosed neurological disorders. * Diagnosis of a psychotic picture entering axis I, DSM-5. * Chronic progressive disease or in remission. * Body mass index \> 30 kg/m2 (i.e. presence of obesity).
Where it's running
-
CHU Lille
Lille, France Recruiting
Study contacts
- Study coordinator: Olivier Cottencin, MD,PhD
- Email: olivier.cottencin@chru-lille.fr
- Phone: 0320445962
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Online brief advice for heavy cannabis users
This project will see if a short online video plus personalized feedback about cannabis withdrawal helps daily cannabis users better understand their use and withdrawal symptoms.
-
Pediatric Congenital Adrenal Hyperplasia: Long-Term Outcomes and Feelings of Regret
This study looks at adults who had classic CAH from 21-hydroxylase deficiency as children to see if early surgeries and management choices are linked to long‑term satisfaction or regret.
-
Predicting Low Cardiac Output in Children After Heart Surgery Using CO2-Derived Parameters
This study tests whether CO2-derived measures can help identify low cardiac output in children after congenital heart surgery.
-
Switching to Ofatumumab: IgG Levels in People with MS
A real-life study tests whether stopping ocrelizumab and starting ofatumumab changes IgG levels in adults with multiple sclerosis who have been on ocrelizumab for at least 18 months.
-
Identifying biomarkers for CAR-T cell therapy in cancer patients
This study looks at real-world CAR-T therapy in adults with blood cancers to see which biomarkers predict who responds or relapses.
-
Long-term real-world follow-up of adults with cutaneous squamous cell carcinoma needing systemic treatment in France
This study tests how adults with cutaneous squamous cell carcinoma who require systemic therapy are managed in real life, using a national French database across multiple centers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.